It is a pharma private limited company based in Parganas North, West Bengal, India, established in 2019.
2019 | Parganas North, West Bengal, India | ActiveNovocardia Life Science Private Limited, a active private limited company, was established on 02 August 2019 in Parganas North, West Bengal, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24110WB2019PTC233252. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Aaditya Kumar (Whole-Time Director), Sweta Nathani (Managing Director), Anshu Kumar Agrawal (Director). Past directors included Aaditya Kumar. It holds ₹1.60 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C/O-,Parimal Moulik, Laxmi Narayan Colony Nabapally,Barasat, Parganas North, West Bengal, 700126.
U24110WB2019PTC233252
233252
02 August 2019
₹0.10 M
₹0.10 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Novocardia Life Science Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aaditya Kumar | Whole-Time Director | 02 Aug 2019 | Current |
| Sweta Nathani | Managing Director | 25 Feb 2023 | Current |
| Anshu Kumar Agrawal | Director | 02 Aug 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Mar 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Novocardia Life Science Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 107.96% increase. The company also saw a substantial improvement in profitability, with a 1831.58% increase in profit. The company's net worth Soared by an impressive increase of 413.92%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Novocardia Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹16,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 May 2025 | Hdfc Bank Limited | ₹5.60 M | Open |
| 15 Dec 2023 | Hdfc Bank Limited | ₹3.50 M | Open |
| 27 Oct 2021 | Hdfc Bank Limited | ₹4.90 M | Open |
| 10 Feb 2021 | Hdfc Bank Limited | ₹2.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Novocardia Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Novocardia Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novocardia Life Science's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Hdfc Bank Limited amounted to Rs. 5.60 M with Charge ID 101090366 was registered on 06 May 2025. was completed.
Progress on Novocardia Life Science Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Novocardia Life Science Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 3.50 M with Charge ID 100850481 was registered on 15 Dec 2023. was documented.
Progress on Sweta Nathani was appointed as a Managing Director was appointed as a Managing Director on 25 Feb 2023 & has been associated with this company since 2 years 9 months . was documented.
A charge with Hdfc Bank Limited amounted to Rs. 4.90 M with Charge ID 100497768 was registered on 27 Oct 2021. was recorded as a recent event.
The CIN of Novocardia Life Science Private Limited is U24110WB2019PTC233252.
Novocardia Life Science Private Limited is headquartered at C/O-,Parimal Moulik, Laxmi Narayan Colony Nabapally,Barasat, Parganas North, West Bengal, 700126.
Novocardia Life Science Private Limited was incorporated on 02 August 2019.
The current directors of Novocardia Life Science Private Limited are
The primary industry of Novocardia Life Science Private Limited is Trade.
Novocardia Life Science Private Limited is unlisted.
The authorized capital of Novocardia Life Science Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX